R. Asciak (SIGGIEWI, Malta), C. Laursen (Odense, Denmark)
This session is built from abstracts published on the ERS Congress platform from 23 August, in a PowerPoint format with a pre-recorded audio narration. The live session is scheduled from September 5-7 and each presenter will have a 5-minutes live, slide show presentation followed at the end of the session by 30-minutes general discussion.
In vitro discrimination between mesothelioma and lung cancer based on headspace volatile profiling E. Janssens (Wilrijk, Belgium), Z. Mol (Ghent, Belgium), L. Vandermeersch (Ghent, Belgium), C. Walgraeve (Ghent, Belgium), J. Van Meerbeeck (Edegem, Belgium), E. Marcq (Wilrijk, Belgium), K. Lamote (Wilrijk, Belgium)
|    |
Breath analysis allows to predict treatment response in malignant pleural mesothelioma patients. E. Schillebeeckx (Wilrijk, Belgium), E. Janssens (Wilrijk, Belgium), V. Surmont (Ghent, Belgium), K. Nackaerts (Leuven, Belgium), J. Van Meerbeeck (Edegem, Belgium), K. Lamote (Wilrijk, Belgium)
|    |
A novel proteomic technique to identify new diagnostic biomarkers for malignant pleural mesothelioma: a feasibility study. E. Schillebeeckx (Wilrijk, Belgium), E. Fernandez (Ghent, Belgium), J. Van Meerbeeck (Edegem, Belgium), K. Gevaert (Ghent, Belgium), K. Lamote (Wilrijk, Belgium)
|    |
The role of monocyte chemoattractant protein-1 (MCP-1) in the development of malignant pleural effusion F. Tekin (Ankara, Turkey), D. Koksal (Ankara, Turkey), Z. Di?kmen (Ankara, Turkey), S. Karahan (Ankara, Turkey), R. Bayler (Ankara, Turkey), B. Ancin (Ankara, Turkey), E. Di?kmen (Ankara, Turkey), D. Akinci (Ankara, Turkey), S. Onder (Ankara, Turkey)
|    |
The relationship between pleural effusion, neural respiratory drive and breathlessness – preliminary results from the SINE study P. Sivakumar (London, United Kingdom), N. Shah (London, United Kingdom), G. Kaltsakas (London, United Kingdom), N. Hart (London, United Kingdom), P. Murphy (London, United Kingdom), L. Ahmed (London, United Kingdom)
|    |
Intracavitary anaesthesia for medical thoracoscopy: a randomised trial M. Gadallah (Alexandria, Egypt), M. Shaheen (Alexandria, Egypt), S. Mourad (Alexandria, Egypt), A. Abdelhady (Alexandria, Egypt), M. Hassan (Alexandria, Egypt)
|    |
Primary cilium modulates mesothelioma cell viability and 3D sphere formation. O. Kotsiou (Larisa, Greece), R. Jagirdar (Larisa, Greece), E. Rouka (Larisa, Greece), E. Pitaraki (Larisa, Greece), K. Gourgoulianis (Larisa, Greece), S. Zarogiannis (Larisa, Greece)
|    |
The frequency of BAP1 and MTAP loss in Benign Asbestos-associated Pleural Inflammation K. Ferguson (Glasgow, United Kingdom), N. Hyndman (Glasgow, United Kingdom), F. Roberts (Glasgow, United Kingdom), K. Blyth (Glasgow, United Kingdom)
|    |
Discussion
|  |